BOTULINUM TOXIN TREATMENT OF FOCAL DYSTONIA IN KERNICTERUS-RELATED MOVEMENT DISORDERS

被引:0
作者
Drion, Emilie [1 ]
Depierreux, Frederique [1 ,2 ,3 ]
机构
[1] Univ Liege, CHU Liege, Dept Neurol, Liege, Belgium
[2] Univ Liege, GIGACRC Vivo Imaging, Liege, Belgium
[3] Univ Liege, Movere Grp, Liege, Belgium
关键词
Botulinum toxin; Focal dystonia treatment; Kernicterus; Upper limb dystonia;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S17 / S18
页数:2
相关论文
共 6 条
  • [1] Clinicopathological Spectrum of Bilirubin Encephalopathy/Kernicterus
    Das, Sumit
    van Landeghem, Frank K. H.
    [J]. DIAGNOSTICS, 2019, 9 (01):
  • [2] Le Pichon JB, 2017, CURR PEDIATR REV, V13, P199, DOI 10.2174/1573396313666170815100214
  • [3] Movement disorders due to bilirubin toxicity
    Rose, Jessica
    Vassar, Rachel
    [J]. SEMINARS IN FETAL & NEONATAL MEDICINE, 2015, 20 (01) : 20 - 25
  • [4] Shapiro S.M., 2012, Care of the jaundiced neonate, P229
  • [5] Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND)
    Shapiro S.M.
    [J]. Journal of Perinatology, 2005, 25 (1) : 54 - 59
  • [6] Bilirubin-Induced Neurologic Damage - Mechanisms and Management Approaches
    Watchko, Jon F.
    Tiribelli, Claudio
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (21) : 2021 - 2030